[2]
Choi M,Scholl UI,Yue P,Björklund P,Zhao B,Nelson-Williams C,Ji W,Cho Y,Patel A,Men CJ,Lolis E,Wisgerhof MV,Geller DS,Mane S,Hellman P,Westin G,Åkerström G,Wang W,Carling T,Lifton RP, K channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (New York, N.Y.). 2011 Feb 11; [PubMed PMID: 21311022]
[3]
Dutta RK,Söderkvist P,Gimm O, Genetics of primary hyperaldosteronism. Endocrine-related cancer. 2016 Oct; [PubMed PMID: 27485459]
[4]
Käyser SC,Deinum J,de Grauw WJ,Schalk BW,Bor HJ,Lenders JW,Schermer TR,Biermans MC, Prevalence of primary aldosteronism in primary care: a cross-sectional study. The British journal of general practice : the journal of the Royal College of General Practitioners. 2018 Feb; [PubMed PMID: 29335324]
[5]
Mulatero P,Stowasser M,Loh KC,Fardella CE,Gordon RD,Mosso L,Gomez-Sanchez CE,Veglio F,Young WF Jr, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. The Journal of clinical endocrinology and metabolism. 2004 Mar; [PubMed PMID: 15001583]
[6]
Williams TA,Reincke M, MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited. European journal of endocrinology. 2018 Jul; [PubMed PMID: 29674485]
[7]
Mattsson C,Young WF Jr, Primary aldosteronism: diagnostic and treatment strategies. Nature clinical practice. Nephrology. 2006 Apr; [PubMed PMID: 16932426]
[8]
Rossi GP,Auchus RJ,Brown M,Lenders JW,Naruse M,Plouin PF,Satoh F,Young WF Jr, An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension (Dallas, Tex. : 1979). 2014 Jan; [PubMed PMID: 24218436]
[9]
Milsom SR,Espiner EA,Nicholls MG,Gwynne J,Perry EG, The blood pressure response to unilateral adrenalectomy in primary aldosteronism. The Quarterly journal of medicine. 1986 Dec; [PubMed PMID: 3659251]
[10]
Parthasarathy HK,Ménard J,White WB,Young WF Jr,Williams GH,Williams B,Ruilope LM,McInnes GT,Connell JM,MacDonald TM, A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. Journal of hypertension. 2011 May; [PubMed PMID: 21451421]
[11]
Hosseinnezhad A,Black RM,Aeddula NR,Adhikari D,Trivedi N, Glucagon-induced pheochromocytoma crisis. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2011 May-Jun [PubMed PMID: 21324811]
[12]
Rimoldi SF,Scherrer U,Messerli FH, Secondary arterial hypertension: when, who, and how to screen? European heart journal. 2014 May 14 [PubMed PMID: 24366917]
[14]
Schiffrin EL,Chrétien M,Seidah NG,Lis M,Gutkowska J,Cantin M,Genest J, Response of human aldosteronoma cells in culture to the N-terminal glycopeptide of pro-opiomelanocortin and gamma 3-MSH. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1983 Apr; [PubMed PMID: 6862354]
[15]
Fujimura J,Nozu K,Yamamura T,Minamikawa S,Nakanishi K,Horinouchi T,Nagano C,Sakakibara N,Nakanishi K,Shima Y,Miyako K,Nozu Y,Morisada N,Nagase H,Ninchoji T,Kaito H,Iijima K, Clinical and Genetic Characteristics in Patients With Gitelman Syndrome. Kidney international reports. 2019 Jan; [PubMed PMID: 30596175]
[16]
Fan P,Lu CX,Zhang D,Yang KQ,Lu PP,Zhang Y,Meng X,Hao SF,Luo F,Liu YX,Zhang HM,Song L,Cai J,Zhang X,Zhou XL, Liddle syndrome misdiagnosed as primary aldosteronism resulting from a novel frameshift mutation of SCNN1B. Endocrine connections. 2018 Nov 1; [PubMed PMID: 30496127]
[17]
Bernini G,Galetta F,Franzoni F,Bardini M,Taurino C,Bernardini M,Ghiadoni L,Bernini M,Santoro G,Salvetti A, Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. Journal of hypertension. 2008 Dec; [PubMed PMID: 19008719]
[18]
Ohno Y,Sone M,Inagaki N,Yamasaki T,Ogawa O,Takeda Y,Kurihara I,Itoh H,Umakoshi H,Tsuiki M,Ichijo T,Katabami T,Tanaka Y,Wada N,Shibayama Y,Yoshimoto T,Ogawa Y,Kawashima J,Takahashi K,Fujita M,Watanabe M,Matsuda Y,Kobayashi H,Shibata H,Kamemura K,Otsuki M,Fujii Y,Yamamoto K,Ogo A,Okamura S,Miyauchi S,Fukuoka T,Izawa S,Yoneda T,Hashimoto S,Yanase T,Suzuki T,Kawamura T,Tabara Y,Matsuda F,Naruse M, Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism: A Multicenter Study in Japan. Hypertension (Dallas, Tex. : 1979). 2018 Mar; [PubMed PMID: 29358460]
[19]
Miyake Y,Tanaka K,Nishikawa T,Naruse M,Takayanagi R,Sasano H,Takeda Y,Shibata H,Sone M,Satoh F,Yamada M,Ueshiba H,Katabami T,Iwasaki Y,Tanaka H,Tanahashi Y,Suzuki S,Hasegawa T,Katsumata N,Tajima T,Yanase T, Prognosis of primary aldosteronism in Japan: results from a nationwide epidemiological study. Endocrine journal. 2014; [PubMed PMID: 24077222]
[20]
Yoshihara F,Nishikimi T,Yoshitomi Y,Nakasone I,Abe H,Matsuoka H,Omae T, Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension. American journal of hypertension. 1996 Jun; [PubMed PMID: 8783775]
[21]
Stowasser M,Sharman J,Leano R,Gordon RD,Ward G,Cowley D,Marwick TH, Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. The Journal of clinical endocrinology and metabolism. 2005 Sep; [PubMed PMID: 15941863]
[22]
Catena C,Colussi G,Nadalini E,Chiuch A,Baroselli S,Lapenna R,Sechi LA, Cardiovascular outcomes in patients with primary aldosteronism after treatment. Archives of internal medicine. 2008 Jan 14; [PubMed PMID: 18195199]
[23]
Hanslik G,Wallaschofski H,Dietz A,Riester A,Reincke M,Allolio B,Lang K,Quack I,Rump LC,Willenberg HS,Beuschlein F,Quinkler M,Hannemann A, Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry. European journal of endocrinology. 2015 Nov; [PubMed PMID: 26311088]
[24]
Sechi LA,Novello M,Lapenna R,Baroselli S,Nadalini E,Colussi GL,Catena C, Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006 Jun 14; [PubMed PMID: 16772627]
[25]
Milliez P,Girerd X,Plouin PF,Blacher J,Safar ME,Mourad JJ, Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. Journal of the American College of Cardiology. 2005 Apr 19; [PubMed PMID: 15837256]